T1	Disease	45 65	lung cancer patients
T2	Limited_variation	71 90	EGFR -mutations had
T3	Phenotype	98 106	PFS with
T4	Chemical	107 118	taxane than
T5	Chemical	119 135	gemcitabine when
T6	Chemical	148 181	platinum -based doublet regimen .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	increases	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T6
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	increases	Arg1:T2	Arg2:T3
R7	influences	Arg1:T2	Arg2:T4
R8	influences	Arg1:T2	Arg2:T5
R9	influences	Arg1:T2	Arg2:T6
R10	treats	Arg1:T3	Arg2:T1
R11	isAssociatedWith	Arg1:T3	Arg2:T2
R12	increases	Arg1:T3	Arg2:T4
R13	treats	Arg1:T4	Arg2:T1
R14	isAssociatedWith	Arg1:T4	Arg2:T2
R15	increases	Arg1:T4	Arg2:T3
R16	influences	Arg1:T4	Arg2:T5
R17	treats	Arg1:T4	Arg2:T6
R18	treats	Arg1:T5	Arg2:T1
R19	isAssociatedWith	Arg1:T5	Arg2:T2
R20	increases	Arg1:T5	Arg2:T3
R21	influences	Arg1:T5	Arg2:T4
R22	influences	Arg1:T5	Arg2:T6
R23	treats	Arg1:T6	Arg2:T1
R24	isAssociatedWith	Arg1:T6	Arg2:T2
R25	increases	Arg1:T6	Arg2:T3
R26	influences	Arg1:T6	Arg2:T4
R27	treats	Arg1:T6	Arg2:T5
